I have comprehensive information from authoritative sources. Here is the full, well-structured answer:
MRI Findings of the Brain in CMV and EBV
Part 1: Cytomegalovirus (CMV) Encephalitis
CMV is a beta-herpesvirus. CNS infection almost exclusively occurs in severely immunocompromised patients - particularly HIV/AIDS with CD4 count <50 cells/µL. Two distinct CNS syndromes exist with different MRI patterns.
CMV Encephalitis (Hematogenous Spread)
Pathologically, CMV spreads hematogenously to cortical and subcortical gray matter, producing microglial nodules and cytomegalic cells.
| Sequence | Finding |
|---|
| T1 (unenhanced) | Decreased signal diffusely in parenchyma; ventriculomegaly |
| T2 / FLAIR | Increased signal intensity outlining the ventricles (periventricular); may be diffuse throughout the parenchyma |
| T1 + Gadolinium | Subependymal / periventricular enhancement - thin line of enhancement bordering the ventricles |
| CT equivalent | Ventriculomegaly; decreased attenuation diffusely |
Key feature: "Pencil-thin" T2/FLAIR periventricular hyperintensity with matching subependymal contrast enhancement - a pattern that distinguishes it from HIV encephalopathy (HAD) and PML. (Dartmouth CNS Infection Radiology; Harrison's Principles of Internal Medicine 22E)
CMV Ventriculoencephalitis (CSF Dissemination)
Occurs more acutely, often on a background of CMV retinitis. The MRI picture is more dramatic:
- Dilated ventricles (prominent ventriculomegaly) - a key distinguishing feature vs. CMV encephalitis
- Brainstem signal changes
- Ependymal enhancement lining the entire ventricular system
- Often associated with cerebellar T2/FLAIR abnormalities
(Bradley and Daroff's Neurology in Clinical Practice, p. 1639)
CMV - Summary of MRI Pattern
The hallmark is periventricular / subependymal disease, reflecting the virus's tropism for ependymal cells and periventricular tissue - the opposite of HIV encephalopathy which preferentially affects white matter.
- MRI is the method of choice (low sensitivity/specificity but best available imaging)
- May be normal in early disease
- Diagnosis confirmed by CSF CMV PCR (positive in <50% of encephalitis, better in ventriculoencephalitis)
Part 2: Epstein-Barr Virus (EBV) Brain Involvement
EBV causes CNS disease through three distinct mechanisms, each with a different MRI pattern:
2A. EBV Encephalitis (Immunocompetent, especially children)
EBV encephalitis is uncommon; MRI is abnormal in 27-80% of patients.
Distribution of involvement (from largest case series of 45 pediatric patients):
| Region | Frequency |
|---|
| Cortical / subcortical | 20% |
| White matter | 15.5% |
| Basal ganglia | 11% |
| Thalamus | 9% |
| Brainstem | 6.2% |
| Substantia nigra | 4.4% |
| Cerebellum | 4.4% |
| Spinal cord | 3% |
Signal characteristics:
- T2 / FLAIR: Hyperintense lesions in the above regions - often cortical/subcortical and basal ganglia
- DWI: Diffusion restriction seen in ~24% of cases
- SWI / GRE: Susceptibility changes (microhemorrhage) in ~15.5%
- Meningeal enhancement on post-contrast T1 in 5-22%
- Brainstem and cerebellar T2/FLAIR hyperintensity is notable in children
- Also in children/adolescents: prominent cerebellar involvement (Harrison's 22E)
(Vyas et al., as cited in PMC10494941)
2B. EBV-Associated Primary CNS Lymphoma (PCNSL) - Most Important CNS Manifestation
EBV is the causative driver of PCNSL in immunocompromised patients (HIV/AIDS, organ transplant recipients). In HIV-AIDS, virtually all PCNSL is EBV-driven.
In Immunocompetent Patients (EBV-negative or EBV-positive PCNSL):
The classic, "textbook" pattern:
| Feature | Finding |
|---|
| T1 | Hypointense to isointense |
| T2 | Iso- to hypointense (dense cellularity - unlike most tumors which are T2 bright) |
| T1 + Gadolinium | Vivid homogeneous enhancement (contact of intact blood-brain barrier in immunocompetent patients) |
| DWI | Restricted diffusion (hypercellular tumor - ADC low) |
| Location | Periventricular deep white matter, corpus callosum, basal ganglia; may show subependymal extension |
| Perfusion | Lower CBV than glioblastoma; lower peak height on perfusion curve |
In Immunocompromised Patients (HIV-associated EBV-driven PCNSL):
The pattern is different and more heterogeneous - mimics toxoplasmosis:
| Feature | Finding |
|---|
| Enhancement | Ring-enhancement (not homogeneous) - due to necrosis |
| T2 | Hyperintense necrotic core with peripheral iso/hypointense rim |
| SWI | Hypointense rim (hemorrhage/hemosiderin) |
| DWI | Peripheral restriction (ring pattern) |
| Necrosis & hemorrhage | More common than in immunocompetent PCNSL |
| Location | Deep, periventricular, often multiple |
| Size | Typically ≥4 cm (larger than toxoplasmosis lesions which are usually <4 cm) |
EBV-positive vs EBV-negative PCNSL (Lee et al.): Tumor necrosis, hemorrhage, and irregular/ring enhancement are significantly more common in EBV-positive PCNSL (P <0.001). (PMC10494941)
2C. EBV Smooth Muscle Tumors (EBV-SMT) - Rare
Seen in severely immunocompromised patients:
- CT: Iso- to hyperdense dural-based extra-axial lesions with substantial enhancement
- MRI T1: Hypo- to isointense
- T2: Prolongation (bright)
- Enhancement: Variable
- DWI: NO restriction (distinguishes from PCNSL)
- Resemble meningiomas or dural metastases
Comparison Table: CMV vs EBV Brain MRI
| Feature | CMV Encephalitis | EBV Encephalitis | EBV-PCNSL (Immunocompetent) | EBV-PCNSL (Immunocompromised) |
|---|
| Pattern | Periventricular | Cortical/BG/WM | Periventricular deep WM | Deep periventricular |
| T2/FLAIR | Periventricular rim | Focal hyperintensity | Iso/hypointense | Hyperintense (necrotic) |
| Enhancement | Subependymal (thin) | Meningeal ± parenchymal | Vivid homogeneous | Ring enhancement |
| DWI | Not prominently restricted | +/- restriction (24%) | Restricted | Peripheral restriction |
| Hemorrhage | Rare | SWI changes ~15% | Rare | Common |
| Mass effect | Minimal | Variable | Present | Present |
| Ventriculomegaly | Yes (especially ventriculoencephalitis) | No | No | No |
| Host | CD4 <50, HIV/AIDS | Children, immunocompetent | Immunocompetent adults | HIV/AIDS, transplant |
| Key biomarker | CSF CMV PCR | CSF EBV PCR / serology | CSF cytology / biopsy | CSF EBV PCR (nearly 100% sensitive in HIV-PCNSL) |
Sources: Bradley and Daroff's Neurology in Clinical Practice (p. 1639-1641); Harrison's Principles of Internal Medicine 22E (p. 1471); Kaplan & Sadock's Comprehensive Textbook of Psychiatry (p. 1868);
Dartmouth CNS Infection Radiology Review;
Unpacking CNS Manifestations of EBV - PMC